These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8211900)

  • 21. [Pancytopenia during the treatment of rheumatoid polyarthritis by low doses of methotrexate. A new case that can question its combination with ranitidine].
    Sichère P; Maudhuit F; Hatem-Schliacowsky N
    Rev Rhum Mal Osteoartic; 1990; 57(7-8):593. PubMed ID: 2281304
    [No Abstract]   [Full Text] [Related]  

  • 22. Methotrexate induced early onset pancytopenia in rheumatoid arthritis: drug allergy? Idiosyncrasy?
    Tanaka Y; Shiozawa K; Nishibayashi Y; Imura S
    J Rheumatol; 1992 Aug; 19(8):1320-1. PubMed ID: 1404178
    [No Abstract]   [Full Text] [Related]  

  • 23. Severe pancytopenia caused by a single administration of low dose methotrexate in a patient undergoing hemodialysis.
    Nakamura M; Sakemi T; Nagasawa K
    J Rheumatol; 1999 Jun; 26(6):1424-5. PubMed ID: 10381078
    [No Abstract]   [Full Text] [Related]  

  • 24. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
    Hocaoglu N; Atilla R; Onen F; Tuncok Y
    Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis.
    Kevat SG; Hill WR; McCarthy PJ; Ahern MJ
    Aust N Z J Med; 1988 Aug; 18(5):697-700. PubMed ID: 3245825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelodysplastic syndrome associated with low-dose methotrexate in rheumatoid arthritis.
    Okamoto H; Teramura M; Kamatani N
    Ann Pharmacother; 2004 Jan; 38(1):172-3. PubMed ID: 14742816
    [No Abstract]   [Full Text] [Related]  

  • 27. Methotrexate induced neutropenia associated with coprescription of penicillins: serious and under-reported?
    Sathi N; Ackah J; Dawson J
    Rheumatology (Oxford); 2006 Mar; 45(3):361-2; author reply 363-4. PubMed ID: 16332953
    [No Abstract]   [Full Text] [Related]  

  • 28. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
    Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pancytopenia in rheumatoid arthritis treated with methotrexate].
    Laroche F; Perrot S; Menkès CJ
    Presse Med; 1996 Sep; 25(25):1144-6. PubMed ID: 8949606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate induced pancytopenia is rare and concern for it should not limit its use.
    Yazici Y
    Rheumatology (Oxford); 2006 Mar; 45(3):361; author reply 363-4. PubMed ID: 16332954
    [No Abstract]   [Full Text] [Related]  

  • 31. Pancytopenia after a single intradermal infiltration of methotrexate.
    Cohen PR; Schulze KE; Nelson BR
    J Drugs Dermatol; 2005; 4(5):648-51. PubMed ID: 16167425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pancytopenia and opportunistic infections in rheumatoid arthritis treated with methotrexate].
    Aspe de la Iglesia B; Sánchez Bursón J; Graña Gil J; Galdo Fernández F
    Rev Clin Esp; 1990 Sep; 187(4):208-9. PubMed ID: 1965337
    [No Abstract]   [Full Text] [Related]  

  • 33. Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event.
    Marshall RW; Marshall VJ; Hull R
    Rheumatology (Oxford); 2006 Mar; 45(3):362-3; author reply 363-4. PubMed ID: 16332952
    [No Abstract]   [Full Text] [Related]  

  • 34. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
    Kinder AJ; Hassell AB; Brand J; Brownfield A; Grove M; Shadforth MF
    Rheumatology (Oxford); 2005 Jan; 44(1):61-6. PubMed ID: 15611303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
    Kremer JM; Habros JS; Kolba KS; Kaine JL; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisemandle W; Mekki QA;
    Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity of low dose methotrexate in rheumatoid arthritis.
    Weinblatt ME
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():35-9. PubMed ID: 3913775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methotrexate therapy of rheumatoid arthritis. An open observation study of 110 patients with median length of treatment of 17.8 month].
    Elling P
    Ugeskr Laeger; 1993 Jul; 155(30):2323-7. PubMed ID: 8346572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serious complications during treatment with methotrexate: also in chronic low-dosage use].
    Rodenburg RJ; Wijnands MJ; Rensma PL
    Ned Tijdschr Geneeskd; 2017; 161():D575. PubMed ID: 28120731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.
    Berkun Y; Levartovsky D; Rubinow A; Orbach H; Aamar S; Grenader T; Abou Atta I; Mevorach D; Friedman G; Ben-Yehuda A
    Ann Rheum Dis; 2004 Oct; 63(10):1227-31. PubMed ID: 15361376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancytopenia related eosinophilia in rheumatoid arthritis.
    Jaffe IA
    J Rheumatol; 1996 Feb; 23(2):406. PubMed ID: 8882061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.